Key result
Contrast-enhanced FDG-PET/CT successfully identified an intensely FDG-avid conglomerate nodal mass causing superior vena cava obstruction in a patient with primary mediastinal T-cell lymphoma.
Why the study?
Does contrast-enhanced FDG PET/CECT aid in the evaluation and staging of mediastinal lymphoma with suspected superior vena cava syndrome?
Case Report (n=1)
Does contrast-enhanced FDG PET/CECT aid in the evaluation and staging of mediastinal lymphoma with suspected superior vena cava syndrome?
Contrast-enhanced FDG-PET/CT is a useful imaging modality for simultaneously staging primary mediastinal T-cell lymphoma and evaluating associated superior vena cava syndrome.
May aid staging and SVC evaluation in mediastinal lymphoma; hypothesis-generating, requires prospective validation.
Positron emission tomography-computed tomography (PET/CT) is a routine investigation for the staging of lymphomas. Contrast-enhanced computed tomography is mandatory whenever parenchymal lesions, especially in the liver and spleen are suspected. We report a rare case of primary mediastinal T-cell lymphoma evaluated with contrast-enhanced PET/CT that showed features of superior vena cava syndrome.
No takes yet. Share an insight, caveat, or question.
Santhosh et al. (2015) conducted a case report in Mediastinal T-cell lymphoma with superior vena cava syndrome (n=1). Contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography (FDG PET/CECT) was evaluated. Contrast-enhanced FDG-PET/CT successfully identified an intensely FDG-avid conglomerate nodal mass causing superior vena cava obstruction in a patient with primary mediastinal T-cell lymphoma.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: